You are here

Article Text

Article menu
Download PDFPDF
Editorial
Glucocorticoid treatment and cardiovascular disease
  1. M K C Ng*,
  2. D S Celermajer*
  1. Department of Medicine, University of Sydney, Australia
  1. Correspondence to:
    Professor David S Celermajer
    Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW 2050, Australia; david.celermajeremail.cs.nsw.gov.au

Abstract

The propensity of glucocorticoids to produce hyperglycaemia, hypertension, dyslipidaemia, and central obesity has long been a cause for concern among physicians regarding possible adverse cardiovascular events. Should heart failure be added to this list of concerns?

  • glucocorticoids
  • hyperglycaemia
  • hypertension
  • dyslipidaemia
  • heart failure

https://doi.org/10.1136/hrt.2003.031492

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • ↵* Also Heart Research Institute, Sydney, Australia